Abstract:The progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer’s, Parkinson’s, Huntington’s disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tissue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in particular therapy has been proposed as an attractive and promising strategy for regenerative medicine due to their unique biological attributes, such as giving rise to neuronal lineage commitment in accordance with the neural development. Nevertheless, stem cell strategy still faces numerous challenges, including ethical issue, tumor formation, and graft rejection. Thus, seeking a more appropriate approach like direct reprogramming or lineage reprogramming is critical. Compared to induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), direct lineage reprogramming of somatic cells to generate induced neurons (iNs) without undergoing a state of pluripotent still has several advantages such as short induction cycle, high transdifferentiation efficiency, no ethical concerns, and risk of neoplasia. On the basis of these advantages, cell reprogramming will hold great promise for therapeutic cell replacement, disease modeling establishment, drug screening, and personalized medicine. Here, we systematically review recent advances in somatic lineage reprogramming into iNs, including the identification of novel reprogramming factors, the underlying molecular mechanisms and the concerns exist, as well as the major challenges in the future.

Direct conversion of adipocyte progenitors into functional neurons.

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Direct Conversion of Somatic Cells into Induced Neurons

Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors

Conversion of Adipose Tissue-Derived Mesenchymal Stem Cells to Neural Stem Cell-Like Cells by A Single Transcription Factor, Sox2

Generation of Patient-Specific Induced Neuronal Cells Using A Direct Reprogramming Strategy

Direct Conversion of Cord Blood CD34+ Cells into Neural Stem Cells by OCT4

Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons.